A61B5/7282

COMPUTERIZED DECISION SUPPORT TOOL AND MEDICAL DEVICE FOR SCRATCH DETECTION AND FLARE PREDICTION

Technology is disclosed for detecting scratch events and predicting flares of pruritus, utilizing motion data sensed from a wearable sensor. Detecting scratch may be done with a two-tier approach by first detecting a hand motion from motion sensed data and then classifying that hand motion as a scratch event using one or more computerized classification models. Embodiments may focus on detecting nighttime scratch by utilizing motion sensed data captured during a user's detected sleep opportunity. Additionally, historical scratch event data may be used to predict a user's itch and flare risk for a future time interval. Decision support tools in the form of computer applications or services may utilize the detected scratch events or predicted itch or flare risk to initiate an action for reducing current itch and/or mitigating future risk, including initiating a treatment protocol that includes therapeutic agent.

METHODS AND SYSTEMS FOR DETERMINATION OF TREATMENT THERAPEUTIC WINDOW, DETECTION, PREDICTION, AND CLASSIFICATION OF NEUROELECTRICAL, CARDIAC, AND/OR PULMONARY EVENTS, AND OPTIMIZATION OF TREATMENT ACCORDING TO THE SAME

Methods and systems implement a variety of sensors, including in embodiments various combinations of EEG sensors, biochemical sensors, photoplethysmography (PPG) sensors, microphones, and accelerometers, to detect, predict, and/or classify various physiological events and/or conditions related to epilepsy, sleep apnea, and/or vestibular disorders. The events can include neuroelectrical events, cardiac events, and/or pulmonary events, among others. In some cases, the method and systems implement trained artificial intelligence (AI) models to detect, classify, and/or predict. The methods and systems are also capable of optimizing a treatment window, suggesting treatments that may improve the overall well-being of the patient (including improving pre- or post-event symptoms and effects), and/or interacting with various care providers.

TECHNIQUE FOR IDENTIFYING A DEMENTIA BASED ON GAZE INFORMATION

Disclosed is a method of identifying dementia by at least one processor of a device. The method includes performing a first task that causes a first object to be displayed on a first region of a screen displayed on a user terminal; and when a preset condition is satisfied, performing a second task that causes at least one object, which induces the user's gaze, to be displayed instead of the first object on the screen of the user terminal.

STATE DETERMINATION METHOD, STATE DETERMINATION DEVICE, STATE DETERMINATION SYSTEM, AND RECORDING MEDIUM

A state determination method, a state determination device, a state determination system, and a recording medium are provided for determining a state of a living body based on electrical signal according to a detected vibration. A state determination device 2 acquires electrical signal according to a detected vibration, and operates: a rectification unit (step S2); an envelope detection unit to derive an envelope from the rectified electrical signal (step S3); and a state determination unit to determine the state of the living body based on the derived envelope (step S4). The state determination device 2 that has determined the state of the living body outputs a determination result (step S5).

Use of biomarkers and therapeutic agents with surgical devices

Biomarkers are collected and used to determine biological propensities of a patient, to determine the efficacy of medical devices, to select and administer therapeutic agents, to select medical devices, to make adjustments to medical devices, and/or to adjust surgical techniques. An apparatus includes a port to draw a biological fluid (e.g., a mist) from a surgical site. The apparatus includes a sensor having a cantilevered beam. The beam includes substances selected to attract certain biomarkers as the fluid is communicated across the beam. The same apparatus or another apparatus is used to administer a therapeutic agent based at least in part on collected biomarker data. The therapeutic agent delivery apparatus may include a device that is also used to create a wound at a surgical site. For instance, a harmonic surgical instrument may be used to both collect biomarkers and administer a therapeutic agent (e.g., gene therapy using sonoporation).

Methods of identifying and locating tissue abnormalities in a biological tissue
11517214 · 2022-12-06 · ·

A method of identifying and locating tissue abnormalities in a biological tissue includes irradiating an electromagnetic signal, via a probe defining a transmitting probe, in the vicinity of a biological tissue. The irradiated electromagnetic signal is received at a probe, defining a receiving probe, after the signal is scattered/reflected by the biological tissue. Blood flow information pertaining to the biological tissue is provided. Based on the received irradiated electromagnetic signal and the blood flow information, tissue properties of the biological tissue are reconstructed. A tracking unit determines the position of at least one of the transmitting probe and the receiving probe while the step of receiving is being carried out, the at least one probe defining a tracked probe. The reconstructed tissue properties are correlated with the determined probe position so that tissue abnormalities can be identified and spatially located.

Method and device for detecting speech patterns and errors when practicing fluency shaping techniques
11517254 · 2022-12-06 · ·

A method and system for detecting errors when practicing fluency shaping exercises. The method includes setting each threshold of a set of thresholds to a respective predetermined initial value; analyzing a voice production to compute a set of first energy levels composing the voice production, wherein the voice production is of a user practicing a fluency shaping exercise; detecting at least one speech-related error based on the computed set of first energy levels, a set of second energy levels, and the set of thresholds, wherein the detection of the at least one speech-related error is with respect to the fluency shaping exercise being practiced by the user, wherein the set of second energy levels is determined based on a calibration process; and generating feedback indicating the detected at least one speech-related error.

HEART SOUND BASED SYNCOPE DETECTION

Systems and methods are disclosed to detect a potential syncope event using cardiac acceleration information of a patient and to transition a medical device from a first low-power mode to a second high-power mode in response to the detected potential syncope event.

Systems and methods for online spike recovery for high-density electrode recordings using convolutional compressed sensing

Systems and methods for performing online spike recovery from multi-channel electrophysiological recordings in accordance with various embodiments of the invention are described. One embodiment of a method of performing online spike recovery from multi-channel electrophysiological recordings includes: determining a set of waveform templates; continuously obtaining multi-channel electrophysiological recordings using a multi-channel electrode; and automatically performing online spike recovery from the multi-channel electrophysiological recordings using a processing system that performs a method for sparse signal recovery that continuously adjusts a processing buffer size based upon newly obtained multi-channel electrophysiological recordings.

Implantable monitoring device and method of operating the implantable monitoring device

An implantable monitoring device includes first sensors to measure state information of one or both of a posture and an activity of a user and second sensors to measure bioinformation of two or more of an electrocardiogram (ECG) of a heart of the user, a pulmonary impedance of a lung of the user, a movement of the heart, a movement of a thorax including the lung, and a respiratory quotient (RQ) of the lung, two electrodes to detect bioinformation to measure one or both of the ECG and the pulmonary impedance, an analog circuit to process the detected bioinformation to measure the one or both of the ECG and the pulmonary impedance, and a processor to monitor an abnormal state of the heart and the lung of the user based on the state information and the bioinformation.